Clinical Trial

The RECLAIM Study.

Name: The RECLAIM Study. — clinical trial record (NCT06450444)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Study acronym: RECLAIM

Recruiting

View on ClinicalTrials.gov →

Summary

The purpose of this study is to evaluate the safety and performance, including clinical benefit, of the PRIMUS System for the treatment of Resistant Migraine.

Protocol Amendment History 9 amendments

This ClinicalTrials.gov record has been amended 9 times since 2024-06-04; most recent amendment 2026-03-26.

Status change: Not Yet Recruiting → Recruiting 2024-08-07

Trial Details

NCT Number	NCT06450444
Lead Sponsor	Salvia BioElectronics
Conditions	Chronic Migraine, High Frequency Episodic Migraine
Enrollment	110 participants
Start Date	2024-06-24
Primary Completion	2027-04-01 (estimated)
Study Completion	2029-01-31 (estimated)
Updated on ClinicalTrials.gov	2026-08-06